Condition (MeSH)
Fructose Intolerance
ClinicalTrials.gov lists 13 trials for Fructose Intolerance or a narrower condition beneath it. Sciotec Diagnostic Technologies GmbH has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
13 of the 13 trials are tagged with Fructose Intolerance itself; the rest are tagged with a narrower condition beneath it.
When did Fructose Intolerance trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2/3
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2023 | 1 |
| 2022 | 1 |
| 2019 | 1 |
| 2018 | 2 |
| 2015 | 1 |
| 2014 | 1 |
| 2011 | 2 |
| 2009 | 1 |
| 2007 | 2 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 13 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Fructose Intolerance trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2/3 | 1 |
| Not applicable | 6 |
| Observational | 6 |
How many Fructose Intolerance trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
| Completed | 7 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Fructose Intolerance trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Sciotec Diagnostic Technologies GmbH | 2 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Alanine | 2 |
| Test meal | 1 |
| No Intervention -- Observational study | 1 |
| Blood Test | 1 |
| placedo | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Fructose Intolerance? (7)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Fecal Calprotectin Elevations Associated with Food Intolerance/Malabsorption Are Significantly Reduced with Targeted Diets. | Nutrients | 2023 | Yes |
| Effect of a high fructose diet on metabolic parameters in carriers for hereditary fructose intolerance. | Clinical nutrition (Edinburgh, Scotland) | 2021 | Yes |
| Extragastrointestinal Symptoms and Sensory Responses During Breath Tests Distinguish Patients With Functional Gastrointestinal Disorders. | Clinical and translational gastroenterology | 2020 | Yes |
| Are heterozygous carriers for hereditary fructose intolerance predisposed to metabolic disturbances when exposed to fructose? | The American journal of clinical nutrition | 2018 | Yes |
| Self-reported dietary fructose intolerance in irritable bowel syndrome: Proposed diagnostic criteria. | World journal of gastroenterology | 2015 | Yes |
Showing 5 of 7 publications.
Prevalence (26)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Hereditary fructose intolerance | Prevalence at birth | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Hereditary fructose intolerance | Point prevalence | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Hereditary fructose intolerance | Point prevalence | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Hereditary fructose intolerance | Prevalence at birth | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Hereditary fructose intolerance | Point prevalence | 1-9 / 1 000 000 | United States | US | Exact |
Showing 5 of 26 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Hereditary fructose intolerance | 469 | Exact | Orphadata Science knowledge files, Product 1 |
| Hereditary fructose intolerance | 469 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.